These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18938111)

  • 1. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
    Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
    Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients.
    Kobayashi R; Okamura S; Ohno T; Saito H; Mori M; Ra C; Okayama Y
    Clin Immunol; 2007 Nov; 125(2):149-58. PubMed ID: 17827066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
    Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
    J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
    Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
    Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
    Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
    J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIP-3α expression in macrophages is NOD dependent.
    Hausmann M; Zeitler C; Weber A; Krebs M; Kellermeier S; Rosenstiel P; de Vallière C; Kosovac K; Fried M; Holler E; Rogler G
    Digestion; 2012; 85(3):192-201. PubMed ID: 22286692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2 receptors in adenopituitary folliculostellate cells: expression and function.
    Correa-de-Santana E; Fröhlich B; Labeur M; Páez-Pereda M; Theodoropoulou M; Monteserin JL; Renner U; Stalla GK
    J Endocrinol; 2009 Oct; 203(1):111-22. PubMed ID: 19608614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
    Watanabe T; Asano N; Murray PJ; Ozato K; Tailor P; Fuss IJ; Kitani A; Strober W
    J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
    Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
    Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and localization of NOD2 protein in human endothelial cells.
    Oh HM; Lee HJ; Seo GS; Choi EY; Kweon SH; Chun CH; Han WC; Lee KM; Lee MS; Choi SC; Jun CD
    Cell Immunol; 2005 Sep; 237(1):37-44. PubMed ID: 16288731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.